CD200 and B-cell chronic lymphocytic leukemia: In the CLL group, 83% (57 of 69) of patients had CD200 positive expression, showing high statistical significance as compared to the controls (P< 0.001), while 10% (4 of 42) of patients with other MBN showed CD200 expression, and had significant difference when compared to CLL (P<0.0001).